HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small molecule modulation of the p75 neurotrophin receptor suppresses age- and genotype-associated neurodegeneration in HIV gp120 transgenic mice.

Abstract
The persistence of HIV in the central nervous system leads to cognitive deficits in up to 50% of people living with HIV even with systemic suppression by antiretroviral treatment. The interaction of chronic inflammation with age-associated degeneration places these individuals at increased risk of accelerated aging and other neurodegenerative diseases and no treatments are available that effectively halt these processes. The adverse effects of aging and inflammation may be mediated, in part, by an increase in the expression of the p75 neurotrophin receptor (p75NTR) which shifts the balance of neurotrophin signaling toward less protective pathways. To determine if modulation of p75NTR could modify the disease process, we treated HIV gp120 transgenic mice with a small molecule ligand designed to engage p75NTR and downregulate degenerative signaling. Daily treatment with 50 mg/kg LM11A-31 for 4 months suppressed age- and genotype-dependent activation of microglia, increased microtubule associated protein-2 (MAP-2), reduced dendritic varicosities and slowed the loss of parvalbumin immunoreactive neurons in the hippocampus. An age related accumulation of microtubule associated protein Tau was identified in the hippocampus in extracellular clusters that co-expressed p75NTR suggesting a link between Tau and p75NTR. Although the significance of the relationship between p75NTR and Tau is unclear, a decrease in Tau-1 immunoreactivity as gp120 mice entered old age (>16 months) suggests that the Tau may transition to more pathological modifications; a process blocked by LM11A-31. Overall, the effects of LM11A-31 are consistent with strong neuroprotective and anti-inflammatory actions that have significant therapeutic potential.
AuthorsYoumie Xie, Jaimie Seawell, Emily Boesch, Lauren Allen, Ashley Suchy, Frank M Longo, Rick B Meeker
JournalExperimental neurology (Exp Neurol) Vol. 335 Pg. 113489 (01 2021) ISSN: 1090-2430 [Electronic] United States
PMID33007293 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • HIV Envelope Protein gp120
  • LM11A-31
  • Ligands
  • Mapt protein, mouse
  • Microtubule-Associated Proteins
  • Morpholines
  • Mtap2 protein, mouse
  • Receptor, Nerve Growth Factor
  • Small Molecule Libraries
  • tau Proteins
  • Isoleucine
Topics
  • Aging
  • Animals
  • Dendrites (pathology)
  • Female
  • Genotype
  • HIV Envelope Protein gp120 (genetics)
  • Hippocampus (pathology)
  • Humans
  • Isoleucine (analogs & derivatives, pharmacology, therapeutic use)
  • Ligands
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microglia (metabolism)
  • Microtubule-Associated Proteins (biosynthesis)
  • Morpholines (pharmacology, therapeutic use)
  • Neurodegenerative Diseases (genetics, pathology)
  • Neurons (pathology)
  • Receptor, Nerve Growth Factor (drug effects, genetics)
  • Small Molecule Libraries
  • tau Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: